Friday, November 17, 2017 3:15:17 PM
There is nothing in this company's past or present (or the CEO's) that shows it is moving forward. Just puff pieces in articles to keep his pipe dream afloat. The failure to purchase the plant in Florida is just the latest (although I don't think they intended to in the first place...just a hunch). Read the business statement again... they started out as only wanting to sell licenses. Having to actually build and run a plant is way out of his league.
Not one person has disproven anything I have written about what he claims this technology can do in the timeframe he says or costs he says. I know there are internal people posting on this board who have an opportunity to prove me wrong if they wanted...so why haven't they? He says he participated in a pilot study with Harvesting Technologies, but when you visit their site...there is not one bit of evidence. When he says DCR Engineering will use their vast clientele to start selling licenses and bolt ons...not one has been sold yet. Hell, they aren't even mentioned in DCR client list!
Last...not one single end user of their product (sugars/lignin) to say it is the most awesome stuff they have ever seen....not one! Mind you, he is only producing tiny lab scale quantities (if that) out of EK Labs...whenever they are there working. His peers don't even recognize him!
The CTS Technology does NOT have the value that Daniel claims, otherwise we wouldn't be talking about how abysmal this stock is.
Show me that there is just ONE business out their willing to buy this technology as a license or bolt on.
a line from a famous movie "If you build it...they will come", or better yet...if you prove it, they will invest.
Magmar out...
Recent BIOF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:34:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:41:18 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 08/17/2023 01:26:03 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 05:43:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM